Navigation Links
Orexigen Resubmits Contrave New Drug Application
Date:12/11/2013

ection with the review of the MAA; even if the NDA is approved by the FDA, the final results of the Light Study may not support continued approval of Contrave; the therapeutic and commercial value of Contrave; and other risks described in Orexigen's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward‐looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these and other risks is included under the heading "Risk Factors" in Orexigen's Current Report on Form 8-K filed with the Securities and Exchange Commission December 2, 2013 and its other reports, which are available from the SEC's website (www.sec.gov) and on Orexigen's website (www.orexigen.com) under the heading "Investor Relations." All forward‐looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.Orexigen Contact: Media Contact: McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Orexigen Therapeutics, Inc. Announces the Closing of its Offering of $115 Million of Convertible Senior Notes
2. Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
6. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
7. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
8. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
9. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
10. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
11. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , December 17, 2014 Revenue ... of expenditure on research and development In the ... its revenue by two percent to EUR 4.287 billion (last ... grew by 14 percent to EUR 360 million. "Overall, 2013/14 ... Dr. Michael Kaschke , President and CEO of Carl ...
(Date:12/17/2014)... Dec. 17, 2014  Northstar Global Business Services, ... Company (DTC) has made their final decision and ... the Company,s stock effective December 15, 2014, and ... for depository and book entry transfer services. All deposit ... now once again fully "DTC Eligible", and has ...
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, Inc. ... music products, today announced that it has signed ... manufacturer and supplier of innovative prosthetic, orthotic and ... part of the agreement, RSL Steeper will promote ... specifically configured for use within UK residential care ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... , , NEW YORK , ... is a new online, print and print-on-demand publication from LIVE STRONG ... fight against cancer; resources and information about cancer prevention and treatment; ... a three-time cancer survivor, I understand the worries and concerns other ...
... , SAN DIEGO , Feb. 9 ... developer and manufacturer of precision intravascular therapy guidance tools designed ... vascular disease, announced today that it has received 510(k) clearance ... the Eagle Eye® Platinum digital IVUS catheter in the ...
Cached Medicine Technology:SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 2SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 3SPOT ON media and LIVESTRONG(R) Launch LIVESTRONG Quarterly 4Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter 2Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter 3Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter 4
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Coalition embarks on "Drive for 3.5" in celebration of National Donate Life ... ... 1, 2008 In celebration of April being,National Donate Life Month, Donate ... 30 seconds to register in the,state,s new organ/tissue donor registry and help ...
... Denny Chipollini inspires others to hit the trails for ... Valley Forge Revolutionary 5-mile Run, ... people would,consider tragedies, 55-year-old Skippack, Pa., resident Denny Chipollini,considers gifts. ... of his leg in a near-fatal car accident and the,contraction ...
... Va., April 1, 2008 The following,is being ... Diabetes Association,s 68th Annual Scientific Sessions., WHEN: ... Moscone Center, San Francisco, CA, WHY: More ... care,professionals from around the world will share cutting-edge ...
... ... Position, ... of product safety testing services,announced today that its Management System Solutions ... party management,system certification services headquartered in Frankfurt am Main, Germany., ...
... Va., April 1, 2008 BurgessGroup,a leading Medicare-based ... signing of a three-year contract renewal with,CalOptima, a ... County,California-based public agency created by the state of ... five County Organized Health Systems (COHS) in the,country, ...
... Do humans hear better than animals? It is known ... are capable of hearing some lower and higher frequencies ... the Hebrew University of Jerusalem and elsewhere have now ... single neurons give humans the capability of detecting fine ...
Cached Medicine News:Health News:Illinoisans Called Upon to Register as Organ & Tissue Donors in Final Push to Reach Campaign Registration Goal 2Health News:Illinoisans Called Upon to Register as Organ & Tissue Donors in Final Push to Reach Campaign Registration Goal 3Health News:For Inspiring Amputee It's No Excuses, No Limits 2Health News:Underwriters Laboratories' Management System Registration Business to Merge With Germany's DQS 2Health News:BurgessGroup Announces Contract Renewal and Software Upgrade by CalOptima 2Health News:Humans have more distinctive hearing than animals, Hebrew U study shows 2
Tapered Shaft Microscissors : Williams Curved SharpTipped Scissors...
Disposable Microscissors: Horizontal, Curved...
Disposable Microscissors: Horizontal, Straight...
Disposable Microscissors: Vertical, 90...
Medicine Products: